Ling Wang

5.7k total citations · 1 hit paper
248 papers, 4.0k citations indexed

About

Ling Wang is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Ling Wang has authored 248 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 54 papers in Pharmacology and 46 papers in Oncology. Recurrent topics in Ling Wang's work include Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (16 papers) and Drug-Induced Hepatotoxicity and Protection (15 papers). Ling Wang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (16 papers) and Drug-Induced Hepatotoxicity and Protection (15 papers). Ling Wang collaborates with scholars based in China, United States and United Kingdom. Ling Wang's co-authors include Xuehua Jiang, Zong‐Guang Zhou, Lie Yang, Bin Zhou, Jun Gu, Chaojie Wang, Hongying Chen, Xiao-Feng Sun, Liang Zheng and Jiang Wu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Nano Letters.

In The Last Decade

Ling Wang

239 papers receiving 3.9k citations

Hit Papers

Estimating Global Prevalence of Metabolic Dysfunction-Ass... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Wang China 33 1.3k 567 454 448 381 248 4.0k
Takahiro Mukai Japan 33 1.1k 0.9× 722 1.3× 723 1.6× 260 0.6× 251 0.7× 227 4.4k
Zhongfa Liu United States 31 2.7k 2.1× 311 0.5× 121 0.3× 1.1k 2.5× 129 0.3× 106 4.3k
Hongtao Zhao China 34 2.4k 1.8× 376 0.7× 209 0.5× 200 0.4× 150 0.4× 143 5.3k
Mariko Nagashima Japan 30 2.6k 2.0× 390 0.7× 679 1.5× 581 1.3× 520 1.4× 137 7.9k
Shinji Kume Japan 42 2.1k 1.6× 268 0.5× 304 0.7× 290 0.6× 1.9k 5.0× 170 6.9k
Zhiguo Zhang China 36 2.4k 1.8× 159 0.3× 156 0.3× 498 1.1× 600 1.6× 133 4.6k
Zhaoqian Liu China 50 4.3k 3.3× 1.9k 3.3× 959 2.1× 1.7k 3.7× 493 1.3× 405 9.6k
Yu Chen China 31 1.1k 0.8× 178 0.3× 477 1.1× 127 0.3× 153 0.4× 159 4.0k
Balázs Sümegi Hungary 43 3.3k 2.5× 1.3k 2.2× 218 0.5× 326 0.7× 472 1.2× 176 6.5k
Takeshi Yoshida Japan 36 1.8k 1.4× 1.0k 1.8× 724 1.6× 610 1.4× 300 0.8× 141 4.4k

Countries citing papers authored by Ling Wang

Since Specialization
Citations

This map shows the geographic impact of Ling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Wang more than expected).

Fields of papers citing papers by Ling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Wang. The network helps show where Ling Wang may publish in the future.

Co-authorship network of co-authors of Ling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Wang. A scholar is included among the top collaborators of Ling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Wang. Ling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wen, Jirui, Ling Wang, Juan Cheng, et al.. (2024). Time‐series transcriptome reveals inflammatory signature in monocytes and neutrophils following acute heat exposure in mine rescuers. Physiological Reports. 12(3). e15946–e15946. 1 indexed citations
3.
Li, Yu, Shiqi Liu, Jin-Hong Chen, et al.. (2023). (2R,6R)-hydroxynorketamine improves PTSD-associated behaviors and structural plasticity via modulating BDNF-mTOR signaling in the nucleus accumbens. Journal of Affective Disorders. 335. 129–140. 11 indexed citations
4.
Ni, Liang, Liang Zheng, Yueyue Liu, et al.. (2023). Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib. Advances in Therapy. 40(10). 4310–4320. 3 indexed citations
6.
Wang, Fangfang, et al.. (2022). PARP1 Upregulation in Recurrent Oral Cancer and Treatment Resistance. Frontiers in Cell and Developmental Biology. 9. 804962–804962. 19 indexed citations
7.
Cao, Dechao, Sushant Khanal, Ling Wang, et al.. (2021). A Matter of Life or Death: Productively Infected and Bystander CD4 T Cells in Early HIV Infection. Frontiers in Immunology. 11. 626431–626431. 32 indexed citations
8.
Arioka, Masaki, Benjamin R. Coyac, Brian Leahy, et al.. (2021). Accelerating Socket Repair via WNT3A Curtails Alveolar Ridge Resorption. Journal of Dental Research. 101(1). 102–110. 10 indexed citations
9.
Wang, Ling, et al.. (2021). Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies. Journal of Analytical Methods in Chemistry. 2021. 1–7. 3 indexed citations
10.
Wang, Ling, et al.. (2019). Preclinical safety profile of disitamab vedotin:a novel anti-HER2 antibody conjugated with MMAE. Toxicology Letters. 324. 30–37. 34 indexed citations
11.
Tang, Jing, Jianming Li, Li Guo, et al.. (2017). Spermidine-mediated poly(lactic-<em>co</em>-glycolic acid)&nbsp;nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis. International Journal of Nanomedicine. Volume 12. 6687–6704. 66 indexed citations
12.
Wang, Ling. (2014). Performance Evaluation of Primary Healthcare System Reform in Xinjin County, Chengdu City:I.Total Performance. Zhongguo xunzheng yixue zazhi. 1 indexed citations
13.
Wang, Zhijun, et al.. (2013). PXR polymorphisms and their impact on pharmacokinetics/pharmacodynamics of repaglinide in healthy Chinese volunteers. European Journal of Clinical Pharmacology. 69(11). 1917–1925. 18 indexed citations
14.
Wang, Ling, Yang Jin, Yke Jildouw Arnoldussen, et al.. (2010). STAMP1 Is Both a Proliferative and an Antiapoptotic Factor in Prostate Cancer. Cancer Research. 70(14). 5818–5828. 46 indexed citations
15.
Wang, Ling, et al.. (2010). Extraction and Determination of Volatile Components in Amomum Villosum Lour. Xiandai shipin keji. 26(9). 1031–1034. 2 indexed citations
16.
Guo, Yi, et al.. (2008). Biochemical pathways in the antiatherosclerotic effect of berberine. Chinese Medical Journal. 121(13). 1197–1203. 17 indexed citations
17.
Wang, Ling. (2007). The Study of Arecoline Hydrobromide's Time-effect and Dose-effect Relationship on Propulsive Ratio of Mice's Small Intestine. 3 indexed citations
18.
Wang, Ling. (2007). Influence of low-modulus of elasticity force on new bone formation of titanium alloy implant-bone interface. Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhi. 1 indexed citations
19.
Zhang, Huarong, Gang Chen, Ling Wang, et al.. (2006). Study on the inclusion complexes of cyclodextrin and sulphonated azo dyes by electrospray ionization mass spectrometry. International Journal of Mass Spectrometry. 252(1). 1–10. 44 indexed citations
20.
Wang, Ling. (2002). Studies on the Glucuronide Conjugates Drugs by ESI-QQ-TOF Mass Spectrometry. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026